Aries Wealth Management Invests $206,000 in Danaher Co. (NYSE:DHR) Stock

Aries Wealth Management purchased a new position in shares of Danaher Co. (NYSE:DHR) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 2,045 shares of the conglomerate’s stock, valued at approximately $206,000.

Several other hedge funds also recently modified their holdings of DHR. GQG Partners LLC bought a new position in shares of Danaher during the second quarter worth about $101,000. Zions Bancorporation lifted its position in shares of Danaher by 118.3% during the third quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock worth $106,000 after purchasing an additional 667 shares during the last quarter. Patten Group Inc. lifted its position in shares of Danaher by 262.3% during the third quarter. Patten Group Inc. now owns 4,830 shares of the conglomerate’s stock worth $114,000 after purchasing an additional 3,497 shares during the last quarter. First Personal Financial Services lifted its position in shares of Danaher by 128.9% during the fourth quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock worth $114,000 after purchasing an additional 691 shares during the last quarter. Finally, Calton & Associates Inc. bought a new position in shares of Danaher during the fourth quarter worth about $114,000. 75.88% of the stock is currently owned by institutional investors and hedge funds.

In other Danaher news, SVP Angela S. Lalor sold 42,988 shares of the firm’s stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $102.29, for a total value of $4,397,242.52. Following the sale, the senior vice president now owns 82,008 shares in the company, valued at $8,388,598.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP William K. Daniel sold 131,066 shares of the firm’s stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $102.05, for a total transaction of $13,375,285.30. Following the transaction, the executive vice president now owns 270,523 shares in the company, valued at approximately $27,606,872.15. The disclosure for this sale can be found here. Insiders sold 237,043 shares of company stock worth $24,194,886 in the last 90 days. 12.20% of the stock is owned by company insiders.

Shares of Danaher Co. (DHR) traded up $0.92 during trading hours on Thursday, hitting $97.02. 248,636 shares of the company’s stock traded hands, compared to its average volume of 2,798,700. Danaher Co. has a 12 month low of $78.97 and a 12 month high of $104.82. The firm has a market capitalization of $66,850.00, a price-to-earnings ratio of 27.65, a P/E/G ratio of 2.00 and a beta of 1.04. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.39.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $1.19 EPS for the quarter, beating the consensus estimate of $1.16 by $0.03. Danaher had a net margin of 13.60% and a return on equity of 11.36%. The company had revenue of $5.09 billion for the quarter, compared to analyst estimates of $4.97 billion. During the same quarter last year, the business earned $1.05 earnings per share. Danaher’s revenue was up 10.9% compared to the same quarter last year. sell-side analysts anticipate that Danaher Co. will post 4.37 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, January 26th. Shareholders of record on Friday, December 29th were paid a $0.14 dividend. The ex-dividend date of this dividend was Thursday, December 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.58%. Danaher’s payout ratio is currently 16.00%.

Several brokerages have recently commented on DHR. Barclays began coverage on shares of Danaher in a research report on Thursday. They set an “overweight” rating and a $110.00 price target on the stock. Credit Suisse Group increased their price target on shares of Danaher from $99.00 to $105.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Zacks Investment Research cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th. Stifel Nicolaus reissued a “buy” rating and issued a $110.00 target price on shares of Danaher in a report on Friday, January 19th. Finally, Robert W. Baird reissued a “buy” rating on shares of Danaher in a report on Friday, January 12th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $100.68.

TRADEMARK VIOLATION WARNING: “Aries Wealth Management Invests $206,000 in Danaher Co. (NYSE:DHR) Stock” was first published by Week Herald and is owned by of Week Herald. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright law. The correct version of this piece of content can be accessed at https://weekherald.com/2018/02/15/aries-wealth-management-buys-shares-of-2045-danaher-co-dhr.html.

Danaher Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply